Higher expression of MEX3A was associated with shorter overall survival only in patients with HPV-negative cervical cancer (p = 0.04) but was not associated with the survival of patients with HPV-positive cervical cancer and all patients with cervical cancer (Figure 7). Here, MEX3A is linked to cervical carcinoma.